Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Strictly Buy and Sell Set Ups -- Ignore unavailable to you. Want to Upgrade?

To: chowder who wrote (13325)	6/27/2008 10:14:38 AM
From: vireya	Read Replies (1) \| Respond to of 13449

so when it starts to pullback, it makes a good short?

To: chowder who wrote (13325)	6/27/2008 10:24:18 AM
From: Zincman	Read Replies (1) \| Respond to of 13449

How much emphasis do you place on volume considering the difference between volume during a price range period, and volume while overhead supply is being taken by demand. Or, is it simply price action that determines your setups? tia ZM

To: chowder who wrote (13325)	6/27/2008 11:45:15 AM
From: Libbyt	Read Replies (1) \| Respond to of 13449

Thanks Dabum for your chart on IMA. It is helpful to see where selling pressure naturally comes into a specific stock. When looking at a company to buy or to sell I like to look at all of the facts and fundamentals of the company. With IMA, there is fairly high institutional ownership. Recently there has been some insider buying, most notably from the CEO who purchased over $1 million dollars of the stock on the open market earlier this month. With high institutional ownership, insider buying, and the end of the quarter, I would rather be long than short IMA. (despite the chart). I appreciate your various charts Dabum, since I realize many people buy or sell based strictly on the the charts. I like to know the fundamentals of a specific company, as well as the chart before I make a decision on if the company is one to buy or sell. online.barrons.com THE OUTLOOK FOR Inverness Medical Innovations (ticker: IMA) looks healthy, if a $1 million stock purchase by the company's chairman and chief executive officer is any indication. "Chairman and CEO Ron Zwanziger on Monday bought 27,600 shares of Inverness, a maker of medical-diagnostic products. He paid an average of $36.16 per share in his first purchase of company stock since September 2004, according to InsiderScore.com." Libbyt